Femara (letrozole) offers new hope for ovarian cancer patients
February 22nd, 2007 Posted by: Dr. Dobson
Researchers at the University of Edinburgh have shown that hormone therapy can extend life in ovarian cancer patients, giving women a new alternative to chemotherapy.
The study, published today in Clinical Cancer Research, has proved for the first time that the targeted use of an anti-oestrogen drug could prolong the life of some patients by up to three years, and delay the use of chemotherapy in others.
Popularity: 5% [?]
Tags: Femara, letrozole, offers, ovarian, cancer, patients